Navigation Links
U of Minn researchers discover genetic cancer link between humans and dogs
Date:2/28/2008

Cancer researchers at the University of Minnesota and North Carolina State University have found that humans and dogs share more than friendship and companionship they also share the same genetic basis for certain types of cancer. Furthermore, the researchers say that because of the way the genomes have evolved, getting cancer may be inevitable for some humans and dogs.

Jaime Modiano, V.M.D., Ph.D., University of Minnesota College of Veterinary Medicine and Cancer Center, and Matthew Breen, Ph.D., North Carolina State Universitys Center for Comparative Medicine and Translational Research, collaborated on this research study. Their findings are published in the current issue of the journal Chromosome Research, a special edition on comparative cytogenetics and genomics research by scientists from around the world.

Genomes are divided into chromosomes, which act as natures biological filing cabinets with genes located in specific places.

Many forms of human cancer are associated with specific alterations to the number or structure of chromosomes and the genes they contain, Breen said. We have developed reagents to show that the same applies to dog cancers, and that the specific genome reorganization which occurs in comparable human and canine cancers shares a common basis.

More specifically, Breen and Modiano found that the genetic changes that occur in dogs diagnosed with certain cancers of the blood and bone marrow, including chronic myelogenous leukemia (CML), Burkitts lymphoma (BL), and chronic lymphocytic leukemia (CLL), are virtually identical to genetic abnormalities in humans diagnosed with the same cancers.

We believe the implication of this finding is that cancer may be the consequence of generations of genetic evolution that has occurred similarly in dogs and humans, Modiano said. This means that to some degree, cancer may be inevitable in some humans and dogs just because of the way our genomes have developed since the sep
'/>"/>

Contact: Sara E. Buss
buss@umn.edu
612-626-7037
University of Minnesota
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. New genetic association with schizophrenia found by researchers
2. Thomson Scientific To Honor Australias Top Researchers With Dedicated Australian Research Day
3. This is your brain on jazz: researchers use MRI to study spontaneity, creativity
4. First look: Princeton researchers peek into deepest recesses of human brain
5. U of Minn researchers find primary alcohol prevention programs are needed for tweens
6. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
7. Researchers identify and shut down protein that fuels ovarian cancer
8. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
9. Penn researchers engineer first system of human nerve-cell tissue
10. LSU researchers study coastal community bounce back
11. University of Sydney researchers find new evidence linking kava to liver damage
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U of Minn researchers discover genetic cancer link between humans and dogs
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ZKB filed another federal ... Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , As ... their Implanon® implants, inability to locate the implants, unsuccessful and invasive attempts at ...
(Date:7/31/2015)... ... 2015 , ... Florida Hospital Tampa has started treating select ... targeted delivery of fluids to selected sites in the peripheral vascular system. Patients ... the device that provides direct, local delivery of chemotherapy to the pancreas. This ...
(Date:7/31/2015)... ... , ... Awarded to only the Top 10 hair transplant practices in the ... latest recipients of the Center of Clinical Excellence for ARTAS Robotic Hair Transplantation ... the science of hair transplant. , Parsa Mohebi Hair Restoration is known worldwide for ...
(Date:7/31/2015)... ... July 31, 2015 , ... Healthpointe , a ... redesigned website at Healthpointe.net. The new website will feature a sleek and streamlined ... serves to provide smoother interactions between patients and the Healthpointe clinics and ensures ...
(Date:7/31/2015)... ... July 31, 2015 , ... The ... Karmanos Center for Natural Birth . The Karmanos Center for Natural Birth ... childbirth experience. With nurses and caregivers that are trained in holistic birth approaches, ...
Breaking Medicine News(10 mins):Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2Health News:Healthpointe Announces Newly Redesigned Website 2
... ... been associated with numerous warnings. If YAZ®/Yasmin® side effects have resulted in ... ... -- The widely-used oral contraceptive YAZ® (alternatively named Yasmin® ) has recently been targeted ...
... 11 Emdeon Inc. (the "Company") today announced the pricing of ... common stock at a price of $15.50 per share. Of the ... were offered by selling stockholders. The shares will be listed on ... the extent that the underwriters sell more than 23,700,000 shares of ...
... , , , ... to repay more than $500 million in benefits that were unlawfully ... part of a class action settlement preliminarily approved by U.S. District ... were suspended or denied between 2000 and 2006 will be notified ...
... , LIONVILLE, Pa., Aug. 11 West ... Federici, Chief Financial Officer, and Michael Anderson, Vice President, Treasurer and Head ... Ideas" Summer Conference on Tuesday, August 18, 2009 in White Plains, NY. ... presentation or a webcast, Mr. Federici and Mr. Anderson will present a ...
... , , , ... Web site , , CHICAGO, Aug. 11 ... o to/publicsurvey and become eligible to win a ... Web site, ADA.org. , , ADA.org provides news and information ...
... , , ATLANTA, Aug. 11 Sean Carroll, CEO ... , has been appointed to serve as a board member of the ... AHI M A ). The ... 1962, is a non-profit organization that provides development, research and scholarships for ...
Cached Medicine News:Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 2Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 3Health News:Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits 4Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 2Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 3Health News:Emdeon Inc. Prices Initial Public Offering of Class A Common Stock at $15.50 Per Share 4Health News:Government Stops Unlawful Social Security Suspensions; Agrees to Repay More Than Half a Billion in Back Benefits 2Health News:American Dental Association Web Survey Offers Chance at $150 Gift Certificate 2Health News:Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 2
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...
(Date:7/30/2015)... 30, 2015  Cleveland Clinic President Wael Barsoum ... last month that industry is compelled to adopt declining ... the efficiencies—and develop the transformational innovations -- required to ... were preceded by Doug Kohrs , past President ... who stressed that industry must add "episode of care," ...
(Date:7/30/2015)...  Medimetriks Pharmaceuticals, Inc. announced today that its ... study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone ... U.S. rights to Ozenoxacin 1% cream.  ... with an emphasis on U.S. patients, involved 412 ... older with a clinical diagnosis of bullous or ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... PRINCETON, N.J., Feb. 2, 2011 Eli Lilly and ... Company (NYSE: BMY ) announced today that ... global Phase III studies evaluating necitumumab, an investigational anti-cancer ... lung cancer (NSCLC). (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) ...
... BOTHELL, Wash., Feb. 2, 2011 Cardiac Science Corporation ... ) and diagnostic cardiac monitoring devices, has been ... Flow Control facilities globally. Tyco Flow Control is a $3.4B ... facilities throughout the globe. The first phase of the rollout, ...
Cached Medicine Technology:Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 2Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 3Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 4Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 5Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 6Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 7Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 8Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 9Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab 10Tyco Division Awards Global AED Contract to Cardiac Science 2Tyco Division Awards Global AED Contract to Cardiac Science 3Tyco Division Awards Global AED Contract to Cardiac Science 4
An enzyme linked immunoassay (ELISA) for the detection and semiquantitationof IgG and IgM antibodies to 2-GP1, as an aid in assessingthe risk of thrombosis in patients with Systemic Lupus Erythematos...
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
The ImagingPlanet 70 mm surgical microscope video adapter: superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
Medicine Products: